Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis

Clinical and Experimental Immunology

Volumn 170, Issue 3, 2012, Pages 266-273

  Arvonen, M ^a   Vahasalo P ^a   Turunen, S ^a   Salo, H M ^b   Maki M ^c   Laurila, K ^c   Vaarala, O ^b   Karttunen, T J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Autoimmunity; MHC class II; Mucosal immunity; Regulatory T cells; Rheumatology

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANTIGEN PRESENTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPT CELL; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILEUM; IMMUNE RESPONSE; JUVENILE RHEUMATOID ARTHRITIS; MALE; PATTERN RECOGNITION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; SMALL INTESTINE MUCOSA;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; ILEUM; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MALE; SIGNAL TRANSDUCTION;

EID: 84868230244     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04663.x     Document Type: Article

References (40)

1. Vaarala O, Atkinson MA, Neu J. The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555-2562.
2. Mielants H, Veys EM, Cuvelier C etal. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy-a prospective study. J Rheumatol 1993; 20:1567-1572.
3. Kokkonen J, Arvonen M, Vahasalo P, Karttunen TJ. Intestinal immune activation in juvenile idiopathic arthritis and connective tissue disease. Scand J Rheumatol 2007; 36:386-389.
4. Arvonen M, Ikni L, Augustin M, Karttunen TJ, Vahasalo P. Increase of duodenal and ileal mucosal cytotoxic lymphocytes in juvenile idiopathic arthritis. Clin Exp Rheumatol 2010; 28:128-134.
5. Picco P, Gattorno M, Marchese N etal. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 2000; 18:773-778.
6. Vaarala O. The gut as a regulator of early inflammation in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2011; 18:241-247.
7. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008; 24:701-706.
8. Savilahti E, Ormala T, Saukkonen T etal. Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation. Clin Exp Immunol 1999; 116:70-77.
9. Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003; 52:2287-2295.
10. Fujimura Y, Hosobe M, Kihara T. Ultrastructural study of M cells from colonic lymphoid nodules obtained by colonoscopic biopsy. Dig Dis Sci 1992; 37:1089-1098.
11. Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci USA 2005; 102:17729-17733.
12. Brandtzaeg P. Review article: homing of mucosal immune cells - a possible connection between intestinal and articular inflammation. Aliment Pharmacol Ther 1997; 11 (Suppl. 3):24-37.
13. Schmutz C, Cartwright A, Williams H etal. Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation. Arthritis Res Ther 2010; 12:R161.
14. Xu B, Cook RE, Michie SA. Alpha4beta7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic mice. J Autoimmun 2010; 35:124-129.
15. Black AP, Bhayani H, Ryder CA, Pugh MT, Gardner-Medwin JM, Southwood TR. An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis. Arthritis Res Ther 2003; 5:R277-284.
16. Saxena N, Misra R, Aggarwal A. Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? Rheumatology (Oxf) 2006; 45:1129-1132.
17. Kokkonen J, Holm K, Karttunen TJ, Maki M. Children with untreated food allergy express a relative increment in the density of duodenal gammadelta+ T cells. Scand J Gastroenterol 2000; 35:1137-1142.
18. Petty RE, Southwood TR, Manners P etal. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31:390-392.
19. Kokkonen J. Lymphoid nodular hyperplasia. In: Guandalini S, ed. Textbook of pediatric gastroenterology and nutrition. London: Taylor & Francis, 2004:479-488.
20. Kokkonen J, Ruuska T, Karttunen TJ, Maki M. Lymphonodular hyperplasia of the terminal ileum associated with colitis shows an increase gammadelta+ T-cell density in children. Am J Gastroenterol 2002; 97:667-672.
21. Turunen S, Karttunen TJ, Kokkonen J. Lymphoid nodular hyperplasia and cow's milk hypersensitivity in children with chronic constipation. J Pediatr 2004; 145:606-611.
22. Holm K, Savilahti E, Koskimies S, Lipsanen V, Maki M. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells. Gut 1994; 35:55-60.
23. Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31:2290-2294.
24. Scott H, Solheim BG, Brandtzaeg P, Thorsby E. HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol 1980; 12:77-82.
25. Mirakian R, Hill S, Richardson A, Milla PJ, Walker-Smith JA, Bottazzo GF. HLA product expression and lymphocyte subpopulations in jejunum biopsies of children with idiopathic protracted diarrhoea and enterocyte autoantibodies. J Autoimmun 1988; 1:263-277.
26. Hirata I, Austin LL, Blackwell WH, Weber JR, Dobbins WO, 3rd. Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease. Dig Dis Sci 1986; 31:1317-1330.
27. Cuvelier C, Mielants H, De Vos M, Veys E, Roels H. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. Gut 1990; 31:545-549.
28. Baecher-Allan C, Viglietta V, Hafler DA. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol 2002; 169:6210-6217.
29. de Waal Malefyt R, Haanen J, Spits H etal. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-924.
30. Donnet-Hughes A, Schiffrin EJ, Huggett AC. Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2 (TGF-beta 2). Clin Exp Immunol 1995; 99:240-244.
31. Round JL, Lee SM, Li J etal. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332:974-977.
32. Koffeman EC, Genovese M, Amox D etal. Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 2009; 60:3207-3216.
33. de Kleer IM, Wedderburn LR, Taams LS etal. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172:6435-6443.
34. Kamphuis S, Albani S, Prakken BJ. Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis. Expert Opin Biol Ther 2006; 6:579-589.
35. Puga Yung GL, Fidler M, Albani E etal. Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease. PLoS ONE 2009; 4:e7714.
36. Vercoulen Y, van Teijlingen NH, de Kleer IM, Kamphuis S, Albani S, Prakken BJ. Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new? Arthritis Res Ther 2009; 11:231.
37. Salmi M, Jalkanen S. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm Bowel Dis 1998; 4:149-156.
38. Fantini MC, Pallone F, Monteleone G. Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. World J Gastroenterol 2009; 15:2472-2478.
39. Wu HJ, Ivanov II, Darce J etal. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815-827.
40. Albani S, Koffeman EC, Prakken B. Induction of immune tolerance in the treatment of rheumatoid arthritis. Nat Rev Rheumatol 2011; 7:272-281.